Johnson & Johnson (JNJ) Shareholder Covington Capital Management Boosted Stake by $483,720; Merck & Co. (MRK) Shareholder Lincluden Management LTD Raised Its Holding

April 24, 2018 - By Marguerite Chambers

Merck & Co., Inc. (NYSE:MRK) Logo

Lincluden Management Ltd increased its stake in Merck & Co. Inc. (MRK) by 39.99% based on its latest 2017Q4 regulatory filing with the SEC. Lincluden Management Ltd bought 23,030 shares as the company’s stock declined 4.63% with the market. The institutional investor held 80,615 shares of the health care company at the end of 2017Q4, valued at $4.54 million, up from 57,585 at the end of the previous reported quarter. Lincluden Management Ltd who had been investing in Merck & Co. Inc. for a number of months, seems to be bullish on the $161.81B market cap company. The stock decreased 0.27% or $0.16 during the last trading session, reaching $60.09. About 12.88 million shares traded or 0.83% up from the average. Merck & Co., Inc. (NYSE:MRK) has declined 14.94% since April 24, 2017 and is downtrending. It has underperformed by 26.49% the S&P500.

Covington Capital Management increased its stake in Johnson & Johnson (JNJ) by 1.53% based on its latest 2017Q4 regulatory filing with the SEC. Covington Capital Management bought 3,480 shares as the company’s stock declined 9.21% with the market. The institutional investor held 230,243 shares of the major pharmaceuticals company at the end of 2017Q4, valued at $32.17M, up from 226,763 at the end of the previous reported quarter. Covington Capital Management who had been investing in Johnson & Johnson for a number of months, seems to be bullish on the $338.52 billion market cap company. The stock decreased 0.50% or $0.64 during the last trading session, reaching $126.19. About 6.51 million shares traded. Johnson & Johnson (NYSE:JNJ) has risen 1.12% since April 24, 2017 and is uptrending. It has underperformed by 10.43% the S&P500.

Investors sentiment decreased to 0.94 in 2017 Q4. Its down 0.12, from 1.06 in 2017Q3. It turned negative, as 94 investors sold MRK shares while 631 reduced holdings. 123 funds opened positions while 558 raised stakes. 1.93 billion shares or 1.34% less from 1.96 billion shares in 2017Q3 were reported. Barbara Oil holds 2.24% of its portfolio in Merck & Co., Inc. (NYSE:MRK) for 62,295 shares. Bnp Paribas Arbitrage Sa invested 0.18% of its portfolio in Merck & Co., Inc. (NYSE:MRK). Lbmc Advsrs Ltd Co reported 5,676 shares. Davis R M stated it has 249,018 shares or 0.55% of all its holdings. Gould Asset Limited Liability Co Ca reported 21,636 shares. Capital Ca has invested 0.07% of its portfolio in Merck & Co., Inc. (NYSE:MRK). Wetherby Asset Inc stated it has 0.71% in Merck & Co., Inc. (NYSE:MRK). Credit Agricole S A has invested 0.01% in Merck & Co., Inc. (NYSE:MRK). Pinnacle Fin Ptnrs reported 0.2% stake. Moreover, Cornercap Inv Counsel has 0.03% invested in Merck & Co., Inc. (NYSE:MRK). Mercer Cap Advisers Inc invested in 1.78% or 43,759 shares. North Corporation invested in 153,979 shares or 1.32% of the stock. Moreover, Alethea Cap Management Lc has 0.88% invested in Merck & Co., Inc. (NYSE:MRK). Chicago Equity Ptnrs Ltd Liability stated it has 0.59% in Merck & Co., Inc. (NYSE:MRK). Gargoyle Investment Advisor Lc accumulated 1.04% or 46,539 shares.

Lincluden Management Ltd, which manages about $1.44B US Long portfolio, decreased its stake in Pfizer Inc (NYSE:PFE) by 14,080 shares to 207,113 shares, valued at $7.50M in 2017Q4, according to the filing. It also reduced its holding in Cae Inc. (NYSE:CAE) by 40,425 shares in the quarter, leaving it with 12,675 shares, and cut its stake in Jp Morgan Chase & Co (NYSE:JPM).

Among 24 analysts covering Merck & Co. Inc. (NYSE:MRK), 21 have Buy rating, 0 Sell and 3 Hold. Therefore 88% are positive. Merck & Co. Inc. had 89 analyst reports since August 13, 2015 according to SRatingsIntel. BMO Capital Markets maintained it with “Buy” rating and $7400 target in Tuesday, June 6 report. BMO Capital Markets maintained the stock with “Outperform” rating in Tuesday, October 31 report. The company was maintained on Thursday, October 26 by Piper Jaffray. UBS maintained the stock with “Buy” rating in Monday, October 30 report. As per Tuesday, March 15, the company rating was maintained by Jefferies. JP Morgan maintained the stock with “Overweight” rating in Monday, September 21 report. The rating was upgraded by Berenberg on Thursday, August 27 to “Hold”. The stock of Merck & Co., Inc. (NYSE:MRK) has “Buy” rating given on Tuesday, November 24 by Berenberg. The stock of Merck & Co., Inc. (NYSE:MRK) earned “Hold” rating by Jefferies on Tuesday, October 31. As per Tuesday, April 17, the company rating was upgraded by Morgan Stanley.

Investors sentiment increased to 0.87 in 2017 Q4. Its up 0.04, from 0.83 in 2017Q3. It is positive, as 35 investors sold JNJ shares while 884 reduced holdings. 143 funds opened positions while 654 raised stakes. 1.72 billion shares or 0.40% more from 1.71 billion shares in 2017Q3 were reported. Agf Invests holds 0.28% or 205,908 shares. Gofen And Glossberg Limited Liability Corporation Il reported 558,138 shares or 2.79% of all its holdings. Regentatlantic Capital reported 164,943 shares. Btc Capital holds 1.46% of its portfolio in Johnson & Johnson (NYSE:JNJ) for 60,647 shares. Adell Harriman And Carpenter Inc invested in 2.32% or 78,389 shares. Rench Wealth Mngmt invested in 2.9% or 31,959 shares. Gamco Invsts Et Al invested in 0.18% or 207,376 shares. Carret Asset Mgmt Ltd Limited Liability Company reported 128,490 shares. Korea Investment Corporation invested 1.39% in Johnson & Johnson (NYSE:JNJ). 10,438 were reported by Annex Advisory Limited Com. Nichols & Pratt Advisers Llp Ma stated it has 710,318 shares or 8.6% of all its holdings. Nadler Finance Gp Inc Inc reported 9,100 shares. Dean Investment Assoc Ltd Liability Com reported 1.13% of its portfolio in Johnson & Johnson (NYSE:JNJ). Moreover, Round Table Services Lc has 0.24% invested in Johnson & Johnson (NYSE:JNJ). Butensky Cohen Fincl Security stated it has 1.75% in Johnson & Johnson (NYSE:JNJ).

Covington Capital Management, which manages about $1.97 billion and $1.62 billion US Long portfolio, decreased its stake in Cvs Health Corp (NYSE:CVS) by 6,232 shares to 71,340 shares, valued at $5.17M in 2017Q4, according to the filing. It also reduced its holding in Blackrock Inc (NYSE:BLK) by 678 shares in the quarter, leaving it with 32,002 shares, and cut its stake in Schwab Strategic Tr (SCHG).

Among 23 analysts covering Johnson & Johnson (NYSE:JNJ), 11 have Buy rating, 5 Sell and 7 Hold. Therefore 48% are positive. Johnson & Johnson had 100 analyst reports since August 7, 2015 according to SRatingsIntel. Leerink Swann maintained Johnson & Johnson (NYSE:JNJ) rating on Wednesday, October 18. Leerink Swann has “Buy” rating and $165.0 target. The stock of Johnson & Johnson (NYSE:JNJ) has “Hold” rating given on Tuesday, September 13 by Jefferies. Stifel Nicolaus maintained Johnson & Johnson (NYSE:JNJ) on Wednesday, January 24 with “Hold” rating. Leerink Swann maintained Johnson & Johnson (NYSE:JNJ) on Wednesday, April 18 with “Buy” rating. The stock of Johnson & Johnson (NYSE:JNJ) has “Outperform” rating given on Wednesday, October 7 by RBC Capital Markets. On Wednesday, October 18 the stock rating was maintained by Wells Fargo with “Buy”. Goldman Sachs upgraded it to “Neutral” rating and $112 target in Monday, March 14 report. Wells Fargo maintained the shares of JNJ in report on Tuesday, February 6 with “Buy” rating. The stock of Johnson & Johnson (NYSE:JNJ) has “Buy” rating given on Thursday, October 19 by Credit Suisse. Stifel Nicolaus maintained it with “Hold” rating and $135 target in Wednesday, April 18 report.

Since February 15, 2018, it had 0 buys, and 1 insider sale for $20.17 million activity.

Merck & Co., Inc. (NYSE:MRK) Institutional Positions Chart

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Posts

>